AAPL345.97+2.06 (+0.60%) ▲|ABBV286.81+0.07 (+0.02%) ▲|ABT104.13-0.76 (-0.72%) ▼|ACN236.65-10.58 (-4.28%) ▼|ADBE249.57-9.05 (-3.50%) ▼|AMAT395.82+8.23 (+2.12%) ▲|AMD559.85+28.57 (+5.38%) ▲|AMGN446.95+2.32 (+0.52%) ▲|AMT183.14-5.15 (-2.73%) ▼|AMZN254.04+4.95 (+1.99%) ▲|AVGO341.92+12.75 (+3.87%) ▲|AXP313.40-1.66 (-0.53%) ▼|BA170.20-18.11 (-9.62%) ▼|BAC50.71+0.19 (+0.37%) ▲|BKNG150.71-2.44 (-1.59%) ▼|BLK1,131.37+3.71 (+0.33%) ▲|BMY61.29-0.32 (-0.52%) ▼|BNY147.72+0.54 (+0.37%) ▲|BRK-B545.02-3.54 (-0.65%) ▼|C122.68+1.64 (+1.35%) ▲|CAT713.23+21.10 (+3.05%) ▲|CL92.06-1.05 (-1.12%) ▼|CMCSA21.81-0.25 (-1.11%) ▼|COF204.16+1.81 (+0.89%) ▲|COP148.20-3.18 (-2.10%) ▼|COST992.04-13.12 (-1.31%) ▼|CRM241.95-5.66 (-2.29%) ▼|CSCO111.53+1.29 (+1.17%) ▲|CVS91.35-1.18 (-1.28%) ▼|CVX229.08-2.93 (-1.26%) ▼|DE639.64-1.61 (-0.25%) ▼|DHR232.12-0.85 (-0.36%) ▼|DIS109.86-0.54 (-0.49%) ▼|DUK124.10-0.34 (-0.27%) ▼|EMR165.60+3.90 (+2.41%) ▲|FDX307.15+6.57 (+2.19%) ▲|GD355.10-1.94 (-0.54%) ▼|GE298.08+9.65 (+3.35%) ▲|GEV887.49+32.87 (+3.85%) ▲|GILD157.94-0.75 (-0.47%) ▼|GM80.55+4.24 (+5.56%) ▲|GOOG318.30+4.11 (+1.31%) ▲|GOOGL321.90+5.10 (+1.61%) ▲|GS911.91+18.63 (+2.09%) ▲|HD318.79-0.59 (-0.18%) ▼|HON217.61-1.67 (-0.76%) ▼|IBM250.38-3.07 (-1.21%) ▼|INTC93.38+2.91 (+3.21%) ▲|INTU326.19-13.70 (-4.03%) ▼|ISRG446.61-5.02 (-1.11%) ▼|JNJ268.49+2.19 (+0.82%) ▲|JPM336.16+2.12 (+0.63%) ▲|KO91.65-1.05 (-1.13%) ▼|LIN507.11-0.45 (-0.09%) ▼|LLY1,281.29+2.15 (+0.17%) ▲|LMT623.94-11.26 (-1.77%) ▼|LOW197.99-0.23 (-0.12%) ▼|LRCX240.52+3.02 (+1.27%) ▲|MA607.95-5.55 (-0.90%) ▼|MCD249.67-1.17 (-0.46%) ▼|MDLZ62.05-0.93 (-1.47%) ▼|MDT94.36-0.43 (-0.45%) ▼|META622.57-8.00 (-1.27%) ▼|MMM171.83-0.96 (-0.56%) ▼|MO73.35-0.28 (-0.37%) ▼|MRK142.18+1.57 (+1.12%) ▲|MS187.39+3.90 (+2.13%) ▲|MSFT531.20-1.40 (-0.26%) ▼|MU931.47+27.77 (+3.07%) ▲|NEE82.19+0.15 (+0.18%) ▲|NFLX62.71-1.20 (-1.87%) ▼|NKE37.44-0.48 (-1.25%) ▼|NOW155.64-2.54 (-1.61%) ▼|NVDA217.78+1.78 (+0.82%) ▲|ORCL131.60+5.54 (+4.39%) ▲|PEP132.66-2.80 (-2.07%) ▼|PFE29.75-0.05 (-0.15%) ▼|PG158.98-0.94 (-0.59%) ▼|PLTR199.44+0.60 (+0.30%) ▲|PM203.18+1.31 (+0.65%) ▲|QCOM181.79+2.19 (+1.22%) ▲|RTX195.29-2.20 (-1.11%) ▼|SBUX102.52-0.18 (-0.17%) ▼|SCHW89.62-0.11 (-0.12%) ▼|SO92.14-0.44 (-0.47%) ▼|SPG211.92-0.77 (-0.36%) ▼|T20.98+0.13 (+0.60%) ▲|TMO698.34+13.45 (+1.96%) ▲|TMUS147.04+0.11 (+0.07%) ▲|TSLA406.03+14.41 (+3.68%) ▲|TXN307.36+9.24 (+3.10%) ▲|UBER65.90-0.24 (-0.36%) ▼|UNH409.45-1.25 (-0.30%) ▼|UNP299.26+2.29 (+0.77%) ▲|UPS105.72+5.40 (+5.38%) ▲|USB59.77+0.07 (+0.11%) ▲|V398.62-5.54 (-1.37%) ▼|VZ43.79+0.69 (+1.59%) ▲|WFC82.76+0.11 (+0.13%) ▲|WMT118.96-1.34 (-1.11%) ▼|XOM180.97-3.57 (-1.93%) ▼|AAPL345.97+2.06 (+0.60%) ▲|ABBV286.81+0.07 (+0.02%) ▲|ABT104.13-0.76 (-0.72%) ▼|ACN236.65-10.58 (-4.28%) ▼|ADBE249.57-9.05 (-3.50%) ▼|AMAT395.82+8.23 (+2.12%) ▲|AMD559.85+28.57 (+5.38%) ▲|AMGN446.95+2.32 (+0.52%) ▲|AMT183.14-5.15 (-2.73%) ▼|AMZN254.04+4.95 (+1.99%) ▲|AVGO341.92+12.75 (+3.87%) ▲|AXP313.40-1.66 (-0.53%) ▼|BA170.20-18.11 (-9.62%) ▼|BAC50.71+0.19 (+0.37%) ▲|BKNG150.71-2.44 (-1.59%) ▼|BLK1,131.37+3.71 (+0.33%) ▲|BMY61.29-0.32 (-0.52%) ▼|BNY147.72+0.54 (+0.37%) ▲|BRK-B545.02-3.54 (-0.65%) ▼|C122.68+1.64 (+1.35%) ▲|CAT713.23+21.10 (+3.05%) ▲|CL92.06-1.05 (-1.12%) ▼|CMCSA21.81-0.25 (-1.11%) ▼|COF204.16+1.81 (+0.89%) ▲|COP148.20-3.18 (-2.10%) ▼|COST992.04-13.12 (-1.31%) ▼|CRM241.95-5.66 (-2.29%) ▼|CSCO111.53+1.29 (+1.17%) ▲|CVS91.35-1.18 (-1.28%) ▼|CVX229.08-2.93 (-1.26%) ▼|DE639.64-1.61 (-0.25%) ▼|DHR232.12-0.85 (-0.36%) ▼|DIS109.86-0.54 (-0.49%) ▼|DUK124.10-0.34 (-0.27%) ▼|EMR165.60+3.90 (+2.41%) ▲|FDX307.15+6.57 (+2.19%) ▲|GD355.10-1.94 (-0.54%) ▼|GE298.08+9.65 (+3.35%) ▲|GEV887.49+32.87 (+3.85%) ▲|GILD157.94-0.75 (-0.47%) ▼|GM80.55+4.24 (+5.56%) ▲|GOOG318.30+4.11 (+1.31%) ▲|GOOGL321.90+5.10 (+1.61%) ▲|GS911.91+18.63 (+2.09%) ▲|HD318.79-0.59 (-0.18%) ▼|HON217.61-1.67 (-0.76%) ▼|IBM250.38-3.07 (-1.21%) ▼|INTC93.38+2.91 (+3.21%) ▲|INTU326.19-13.70 (-4.03%) ▼|ISRG446.61-5.02 (-1.11%) ▼|JNJ268.49+2.19 (+0.82%) ▲|JPM336.16+2.12 (+0.63%) ▲|KO91.65-1.05 (-1.13%) ▼|LIN507.11-0.45 (-0.09%) ▼|LLY1,281.29+2.15 (+0.17%) ▲|LMT623.94-11.26 (-1.77%) ▼|LOW197.99-0.23 (-0.12%) ▼|LRCX240.52+3.02 (+1.27%) ▲|MA607.95-5.55 (-0.90%) ▼|MCD249.67-1.17 (-0.46%) ▼|MDLZ62.05-0.93 (-1.47%) ▼|MDT94.36-0.43 (-0.45%) ▼|META622.57-8.00 (-1.27%) ▼|MMM171.83-0.96 (-0.56%) ▼|MO73.35-0.28 (-0.37%) ▼|MRK142.18+1.57 (+1.12%) ▲|MS187.39+3.90 (+2.13%) ▲|MSFT531.20-1.40 (-0.26%) ▼|MU931.47+27.77 (+3.07%) ▲|NEE82.19+0.15 (+0.18%) ▲|NFLX62.71-1.20 (-1.87%) ▼|NKE37.44-0.48 (-1.25%) ▼|NOW155.64-2.54 (-1.61%) ▼|NVDA217.78+1.78 (+0.82%) ▲|ORCL131.60+5.54 (+4.39%) ▲|PEP132.66-2.80 (-2.07%) ▼|PFE29.75-0.05 (-0.15%) ▼|PG158.98-0.94 (-0.59%) ▼|PLTR199.44+0.60 (+0.30%) ▲|PM203.18+1.31 (+0.65%) ▲|QCOM181.79+2.19 (+1.22%) ▲|RTX195.29-2.20 (-1.11%) ▼|SBUX102.52-0.18 (-0.17%) ▼|SCHW89.62-0.11 (-0.12%) ▼|SO92.14-0.44 (-0.47%) ▼|SPG211.92-0.77 (-0.36%) ▼|T20.98+0.13 (+0.60%) ▲|TMO698.34+13.45 (+1.96%) ▲|TMUS147.04+0.11 (+0.07%) ▲|TSLA406.03+14.41 (+3.68%) ▲|TXN307.36+9.24 (+3.10%) ▲|UBER65.90-0.24 (-0.36%) ▼|UNH409.45-1.25 (-0.30%) ▼|UNP299.26+2.29 (+0.77%) ▲|UPS105.72+5.40 (+5.38%) ▲|USB59.77+0.07 (+0.11%) ▲|V398.62-5.54 (-1.37%) ▼|VZ43.79+0.69 (+1.59%) ▲|WFC82.76+0.11 (+0.13%) ▲|WMT118.96-1.34 (-1.11%) ▼|XOM180.97-3.57 (-1.93%) ▼|
14.6 C
New York
Tuesday, October 27, 2026

Tag: prime

newsFORsourcecompanycontentinformation1releasesmarket

UNBEATABLE PRIME DAY DEALS-UP TO 40% OFF ON DASH’S VIRAL KITCHEN ESSENTIALS

Transform your kitchen and summer entertaining with exclusive Prime Day savings! NEW YORK, June 30, 2025 /PRNewswire/ -- Amazon Prime Day is here, and Dash...

Canada’s internal trade barriers are finally coming down, but patchwork of government approaches could create new challenges

CFIB's 2025 internal trade report card sees major improvements from provinces introducing mutual recognition legislation TORONTO, June 30, 2025 /CNW/ - More progress has been...

Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London

LUND, Sweden, June 30, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), announced today the presentation of its five year extended pooled...

Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London

LUND, Sweden, June 30, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), announced today the presentation of its five year extended pooled...

Haffner Energy publie ses résultats annuels de l’exercice 2024-2025

 

Online Payday Loans with Same Day Approval No Credit Check – Radcred Launches Instant Loan Platform for US Borrowers

Radcred offers same-day payday loans online with no credit check. Apply for instant payday loans today, even with bad credit, and get fast approval! 
Radcred offers same-day payday loans online with no credit check. Apply for instant payday loans today, even with bad credit, and get fast approval!

No Credit Check Loans Explained: Low Credit Finance Releases U.S. Borrower Education Guide

The new borrower-focused guide from Low Credit Finance outlines how no credit check loans work, who qualifies, and what to expect during the U.S. application process. 
The new borrower-focused guide from Low Credit Finance outlines how no credit check loans work, who qualifies, and what to expect during the U.S. application process.

UPDATE — Gemini to List Dinari’s Tokenized U.S. Equities, Bringing Access to European Investors

Gemini to List Dinari’s Tokenized U.S. Equities, Bringing Access to European Investors

Gemini to List Dinari’s Tokenized U.S. Equities, Bringing Access to European Investors

Gemini to List Dinari’s Tokenized U.S. Equities, Bringing Access to European and APAC Investors

Saks Global Secures $600 Million in Committed Financing from Existing Bondholders

Company Secures $400 Million FILO Facility and $200 Million in Additional Incremental Commitments Transaction Significantly Bolsters Liquidity and Fortifies Balance Sheet as Company Continues to...

INmune Bio, Inc. Announces Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Boca Raton, Florida, June 27, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it has entered into securities purchase agreements with two healthcare focused institutional investors for the purchase and sale of 3,000,000 shares of its common stock in a registered direct offering (the "Offering") at a purchase price of $6.30 per share, priced at-the-market under Nasdaq rules.

Breescape Launches Early Prime Day Sale with Award-Winning Cooling Bedding

Experience Instant Coolness and Sweat-Free Sleep This Summer with Breescape's Patented BlendTek™ Technology NEW YORK, June 27, 2025 /PRNewswire/ -- Breescape™ dedicated to delivering uninterrupted cooling...

Unlock Generational Wealth: Top 3 Stocks Every Woman Should Invest In

Hey fabulous ladies! If you're dreaming of building wealth that lasts, let's dive into some stocks that could help you do just that. Here...

Peer-Reviewed Study in Nature Scientific Reports Demonstrates Non-Invasive Fat Reduction Using Alma’s Energy-Based Technology

CAESAREA, Israel, June 27, 2025 /PRNewswire/ -- A newly published, peer-reviewed study in Nature Scientific Reports, part of the prestigious Nature Portfolio, presents compelling clinical...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPrime

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers